TendoMend is developing a minimally invasive implant and a corresponding deployment system, aiming to replace the traditional outdated suturing approach in tendon repair.


INTRAGEL is a science-based company engaged in developing an innovative, state-of-the-art treatment for solid tumors based on an intra-tumoral injectable delivery system with extended-release of anticancer drugs.


OTTek has developed the FIOT (Flow In Over Tube), a versatile, on-demand, easy-to-assemble, cost-effective, colonoscopy assist device.


Epidutech is developing a revolutionary system for minimally invasive lumbar spine surgery, by a precision motor driven and electromagnetically guided flexible metal catheter.


EIO Biomedical is an innovative biotechnology company developing a medical device for the prevention of post-surgical adhesions.


Addressing Valve Insufficiency CUSPA is developing the CUSPER®, an artificial cusp connected to a grasper that is attached to the native valve cusp/leaflet for aortic valve insufficiency (AI).


We at Synnerva have developed a new technological platform for the concurrent increase of CNS efficacy while dramatically reducing their side effects. . RVX’s method is based on a combination


Nina Medical develops focal therapy technologies, expanding the scope of next generation medicine. In focal therapy, surgeon’s knife is replaced with a therapeutic beam of focused energy, directed to the

Elgan Pharma

We named our company ELGAN Pharma, as we are dedicated to improving outcome for babies who are Extremely Low Gestational Age Newborns (ELGANs). This means they are born more than